Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

L-Carnitine and Reduced Apolipoprotein B/Apolipoprotein A1 Ratio

Doses used in studies

mg/kg/day: 50 (median 50, IQR 50–50) — 1 study

Time to effect

Median: 10 weeks · IQR 10 weeks–10 weeks · Range 10 weeks–10 weeks — Reported in 1 of 1 study

1 of 1 paper

Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial.
- 2021-05-26
- RCT · n = 30
- Pediatric nephrology (Berlin, Germany) 36(11)
- - Fatemeh Hamedi-Kalajahi
  - Meysam Zarezadeh
  - Sayed Yousef Mojtahedi
  - Sakineh Shabbidar
  - Dariyoosh Fahimi
  - Hossein Imani
- PubMed: 34037885
- DOI: 10.1007/s00467-021-05080-1
7 Insights on
- Reduced Apolipoprotein B/Apolipoprotein A1 Ratio
- High evidence
- Clinical
Oral L-carnitine supplementation led to decreased ApoB levels and ApoB/ApoA1 ratio, but these changes were not significant compared to placebo.
Effect
Neutral
Effect size
Small
Significant
No
Dose
50 mg/kg/day